• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Eli Lilly booth at ASCO 2026
Biotech

ASCO: Lilly's faith in Kelonia rewarded with ‘nutty’ CAR-T data

Kelonia shared the largest slice of data yet for its in vivo CAR-T, helping to justify the $3.2 billion price tag Lilly recently paid for the biotech.
Darren Incorvaia May 31, 2026 8:00am
Gilead  Kite booth at AACR 2026

ASCO: Tubulis touts ovarian cancer data that attracted Gilead

May 30, 2026 9:36am
Graphic of a fork in the road with arrows pointing in either direction

ASCO: BioNTech/BMS, Pfizer split on bispecific approach in NSCLC

May 30, 2026 3:30pm
ASCO
Favicon Fierce Pharma

Akeso's 34% overall survival win comes with caveats

May 31, 2026 8:00am
Revolution Medicines booth at ASCO 2026

ASCO: RevMed confident in RAS leadership as rivals square up

May 31, 2026 8:00am
Fan

ASCO: Legend scientific founder returns with new CAR-T ambition

May 29, 2026 2:00pm
More News

AstraZeneca, after phase 3 miss, posts data behind approval bid

May 29, 2026 10:15am

Agios’ next-gen PK drug fails ph. 2 blood cancer study

May 29, 2026 9:13am

Boston, China and the future of biotech

May 29, 2026 9:09am

Allogene swaps in CMO as new chief exec—Chutes & Ladders

May 29, 2026 8:30am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings